Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-10-26
1992-09-22
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 4, 530303, A61K 3726, A61K 3702
Patent
active
051497166
ABSTRACT:
The invention relates to insulin derivatives of the formula III ##STR1## in which R.sup.30 and R.sup.31 together are OH, or R.sup.30 is a radical of a neutral, genetically encodable L-amino acid and R.sup.31 is OH or a physiologically acceptable organic group of basic character having up to 50 carbon atoms, whose synthesis involves 0 to 3 .alpha.-amino acids and whose optional terminal carboxyl function can be present free, as an ester function, as an amide function, as a lactone or reduced to CH.sub.2 OH, and R.sup.A-1 is a radical of a genetically encodable L-amino acid, and physiologically acceptable salts of said insulin derivative of the formula III.
REFERENCES:
patent: 4608364 (1986-08-01), Grau
patent: 4701440 (1987-10-01), Grau
CA 93: 198218P (1980) Roesen et al.
Rosen et al. Biochem J vol. 186 (1980) 945-952.
Rose et al., Advances In Protein Chemistry vol. 37 25-31 (1985).
Advances in Protein Chemistry, Anfinsen et al., Academic Press, pp. 340-347 (1972).
Biochemistry, Lehninger, Worth Publishers Inc., pp. 71-76 (1977).
Bicker Richard
Geisen Karl
Vertesy Laszlo
Cashion Jr. Merrell C.
Celsa B.
Hoechst Aktiengesellschaft
LandOfFree
Insulin derivatives, process for their preparation, their use an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Insulin derivatives, process for their preparation, their use an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin derivatives, process for their preparation, their use an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1068620